Latest Insider Transactions at Rivian Automotive, Inc. (RIVN)
This section provides a real-time view of insider transactions for Rivian Automotive, Inc. (RIVN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Rivian Automotive, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Rivian Automotive, Inc. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Claire Mc Donough Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,210
-0.84%
|
$32,100
$10.03 P/Share
|
|
Nov 15
2024
|
Claire Mc Donough Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,954
-2.79%
|
$109,540
$10.31 P/Share
|
|
Nov 15
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,165
-2.61%
|
$231,650
$10.31 P/Share
|
|
Oct 21
2024
|
Peter Krawiec Director |
BUY
Grant, award, or other acquisition
|
Direct |
985
+1.55%
|
-
|
|
Oct 21
2024
|
Sanford Harold Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,527
+0.89%
|
-
|
|
Oct 21
2024
|
Rose M Marcario Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+1.49%
|
-
|
|
Sep 23
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
83,333
-8.59%
|
$916,663
$11.64 P/Share
|
|
Sep 23
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,333
+7.91%
|
$166,666
$2.63 P/Share
|
|
Sep 12
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
83,333
-8.59%
|
$1,083,329
$13.68 P/Share
|
|
Sep 12
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,333
+7.91%
|
$166,666
$2.63 P/Share
|
|
Aug 16
2024
|
Claire Mc Donough Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,210
-0.81%
|
$41,730
$13.57 P/Share
|
|
Aug 15
2024
|
Claire Mc Donough Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,550
-2.36%
|
$124,150
$13.25 P/Share
|
|
Aug 15
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,165
-2.55%
|
$301,145
$13.25 P/Share
|
|
Jul 27
2024
|
Jeff Baker Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
104,849
-93.54%
|
-
|
|
Jul 22
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,429
-3.78%
|
$1,214,293
$17.02 P/Share
|
|
Jul 22
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,429
+3.64%
|
$142,858
$2.63 P/Share
|
|
Jul 22
2024
|
Sanford Harold Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+0.97%
|
-
|
|
Jul 22
2024
|
Peter Krawiec Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+1.7%
|
-
|
|
Jul 22
2024
|
Rose M Marcario Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,707
+1.59%
|
-
|
|
Jul 12
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
200,000
-18.02%
|
$3,600,000
$18.0 P/Share
|
|
Jul 12
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+15.27%
|
$400,000
$2.63 P/Share
|
|
Jul 08
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,429
-7.28%
|
$1,000,006
$14.97 P/Share
|
|
Jul 08
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,429
+6.79%
|
$142,858
$2.63 P/Share
|
|
Jun 25
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,429
-7.28%
|
$785,719
$11.25 P/Share
|
|
Jun 25
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,429
+6.79%
|
$142,858
$2.63 P/Share
|
|
Jun 18
2024
|
Karen Boone Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+22.9%
|
-
|
|
Jun 18
2024
|
Peter Krawiec Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+28.56%
|
-
|
|
Jun 18
2024
|
Rose M Marcario Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+18.9%
|
-
|
|
Jun 18
2024
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+14.4%
|
-
|
|
Jun 18
2024
|
John Krafcik Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+36.2%
|
-
|
|
Jun 18
2024
|
Sanford Harold Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,224
+12.72%
|
-
|
|
Jun 10
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,429
-7.28%
|
$785,719
$11.49 P/Share
|
|
Jun 10
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,429
+6.79%
|
$142,858
$2.63 P/Share
|
|
May 16
2024
|
Claire Mc Donough Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,210
-0.79%
|
$32,100
$10.25 P/Share
|
|
May 15
2024
|
Jeff Baker Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,020
-7.67%
|
$44,220
$11.19 P/Share
|
|
May 15
2024
|
Kjell Gruner Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,700
-2.38%
|
$106,700
$11.19 P/Share
|
|
May 15
2024
|
Claire Mc Donough Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,029
-0.98%
|
$44,319
$11.19 P/Share
|
|
May 15
2024
|
Robert J Scaringe Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,739
-0.74%
|
$74,129
$11.19 P/Share
|
|
May 13
2024
|
Claire Mc Donough Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
247,580
+37.5%
|
-
|
|
May 13
2024
|
Robert J Scaringe Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
429,138
+31.89%
|
-
|
|
Apr 22
2024
|
Pamela Thomas Graham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,595
+2.76%
|
-
|
|
Apr 22
2024
|
Sanford Harold Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,705
+1.19%
|
-
|
|
Apr 22
2024
|
Rose M Marcario Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+2.03%
|
-
|
|
Apr 22
2024
|
Peter Krawiec Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+2.94%
|
-
|
|
Mar 11
2024
|
Jeff Baker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
31,425
-37.48%
|
$408,525
$13.18 P/Share
|
|
Mar 08
2024
|
Kjell Gruner Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
19,935
-4.66%
|
$239,220
$12.81 P/Share
|
|
Mar 01
2024
|
Jeff Baker Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,437
-6.09%
|
$59,807
$11.32 P/Share
|
|
Mar 01
2024
|
Jeff Baker Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,238
+14.58%
|
-
|
|
Mar 01
2024
|
Kjell Gruner Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,537
-0.36%
|
$16,907
$11.32 P/Share
|
|
Mar 01
2024
|
Kjell Gruner Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,306
+0.99%
|
-
|